FLUZONE TRIVALENT SUBVIRION SUSPENSION
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
A/PANAMA/2007/99 (H3N2) -LIKE STRAIN; A/NEW CALEDONIA/20/99(H1N1)-LIKE STRAIN; B/HONG KONG/1434/2002-LIKE STRAIN
Available from:
SANOFI PASTEUR LIMITED
ATC code:
J07BB02
INN (International Name):
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Dosage:
15MCG; 15MCG; 15MCG
Pharmaceutical form:
SUSPENSION
Composition:
A/PANAMA/2007/99 (H3N2) -LIKE STRAIN 15MCG; A/NEW CALEDONIA/20/99(H1N1)-LIKE STRAIN 15MCG; B/HONG KONG/1434/2002-LIKE STRAIN 15MCG
Administration route:
INTRAMUSCULAR
Units in package:
0.5/5ML
Prescription type:
Schedule D
Therapeutic area:
VACCINES
Product summary:
Active ingredient group (AIG) number: 0349402001; AHFS:
Authorization status:
CANCELLED POST MARKET
Authorization date:
2007-08-14
